Cognitive performance of patients with chronic heart failure on sacubitril/valsartan View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2018-02-15

AUTHORS

R. De Vecchis, C. Ariano, G. Di Biase, M. Noutsias

ABSTRACT

BackgroundSacubitril, a neprilysin inhibitor in the combination molecule sacubitril/valsartan, slows down degradation of endogenous natriuretic peptides, thereby enhancing their beneficial cardiovascular effects. However, sacubitril might also promote neuronal dysfunction and cognitive impairment in patients with chronic heart failure (CHF) treated with sacubitril/valsartan, due to possible neprilysin inhibition at the level of Central Nervous System.MethodsA retrospective cohort study was undertaken to detect the effects exerted by sacubitril/valsartan on cognitive function in CHF patients. The patients’ clinical data were examined for information provided in the Mini-Mental State Examination (MMSE), which was routinely administered during clinical visits at two centers from 15 March to 31 October 2017. Patients in the sacubitril/valsartan group had a clinical history of at least 3 months of continuous sacubitril/valsartan administration. The control group comprised CHF patients on conventional therapy not taking sacubitril/valsartan. In the between-group comparison, patients were matched for mean age, educational level, sex, NYHA class, and comorbidities. In the present retrospective study only patients in NYHA class II-III were enrolled.ResultsThe mean MMSE score was 22.72 ± 2.68 (mean ± standard deviation [SD]) in the sacubitril/valsartan group (n = 51 patients) vs. 21.96 ± 2.73 (mean ± SD) in the control group (n = 51; p = 0.1572, independent samples t-test). Thus, a similar mild-to-moderate impairment in cognitive performance was found in the comparison between the two groups.ConclusionIn our study, we did not find any evidence of the alleged harmful influence of sacubitril/valsartan on cognitive function. Patients taking sacubitril/valsartan for at least 3 months had similar mean MMSE scores to control subjects. More... »

PAGES

534-540

References to SciGraph publications

  • 2016-12-15. Long-term neprilysin inhibition — implications for ARNIs in NATURE REVIEWS CARDIOLOGY
  • 2017-02-03. Relationship between cognitive function and regulation of cerebral blood flow in THE JOURNAL OF PHYSIOLOGICAL SCIENCES
  • 2017-09-22. Acute heart failure in HERZ
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1007/s00059-018-4683-5

    DOI

    http://dx.doi.org/10.1007/s00059-018-4683-5

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1101042334

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/29450561


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Cardiorespiratory Medicine and Haematology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aminobutyrates", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Angiotensin II Type 1 Receptor Blockers", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Angiotensin Receptor Antagonists", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Cognition", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Combinations", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Heart Failure", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Retrospective Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Stroke Volume", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Tetrazoles", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Valsartan", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Preventive Cardiology and Rehabilitation Unit, DSB 29 \u201cS.\u00a0Gennaro dei Poveri Hospital\u201d, via S.\u00a0Gennaro dei Poveri\u00a025, 80136, Naples, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Preventive Cardiology and Rehabilitation Unit, DSB 29 \u201cS.\u00a0Gennaro dei Poveri Hospital\u201d, via S.\u00a0Gennaro dei Poveri\u00a025, 80136, Naples, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "De Vecchis", 
            "givenName": "R.", 
            "id": "sg:person.0704361014.79", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704361014.79"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Geriatrics, \u201cCasa Sollievo della Sofferenza\u201d Hospital, viale Cappuccini\u00a02, 71013, San Giovanni Rotondo, Italy", 
              "id": "http://www.grid.ac/institutes/grid.413503.0", 
              "name": [
                "Division of Geriatrics, \u201cCasa Sollievo della Sofferenza\u201d Hospital, viale Cappuccini\u00a02, 71013, San Giovanni Rotondo, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ariano", 
            "givenName": "C.", 
            "id": "sg:person.0660263343.51", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660263343.51"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Division of Geriatrics, Clinic \u201cS. Maria del Pozzo\u201d, via Pomigliano\u00a040, 80049, Somma Vesuviana, Italy", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "Division of Geriatrics, Clinic \u201cS. Maria del Pozzo\u201d, via Pomigliano\u00a040, 80049, Somma Vesuviana, Italy"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Di Biase", 
            "givenName": "G.", 
            "id": "sg:person.01066703417.19", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066703417.19"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Mid-German Heart Center, Department of Internal Medicine III, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Halle, Martin Luther University Halle-Wittenberg, Ernst-Grube-Stra\u00dfe\u00a040, 06120, Halle, Germany", 
              "id": "http://www.grid.ac/institutes/grid.461820.9", 
              "name": [
                "Mid-German Heart Center, Department of Internal Medicine III, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Halle, Martin Luther University Halle-Wittenberg, Ernst-Grube-Stra\u00dfe\u00a040, 06120, Halle, Germany"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Noutsias", 
            "givenName": "M.", 
            "id": "sg:person.01077606445.25", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077606445.25"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1038/nrcardio.2016.200", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1003829077", 
              "https://doi.org/10.1038/nrcardio.2016.200"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00059-017-4626-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1091896405", 
              "https://doi.org/10.1007/s00059-017-4626-6"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s12576-017-0525-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1083524408", 
              "https://doi.org/10.1007/s12576-017-0525-0"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2018-02-15", 
        "datePublishedReg": "2018-02-15", 
        "description": "BackgroundSacubitril, a\u00a0neprilysin inhibitor in the combination molecule sacubitril/valsartan, slows down degradation of endogenous natriuretic peptides, thereby enhancing their beneficial cardiovascular effects. However, sacubitril might also  promote neuronal dysfunction and cognitive impairment in patients with  chronic heart failure (CHF) treated with sacubitril/valsartan, due to possible neprilysin inhibition at the level of Central Nervous System.MethodsA\u00a0retrospective cohort study was undertaken to detect the effects exerted by sacubitril/valsartan on cognitive function in CHF patients. The patients\u2019 clinical data were examined for information provided in the Mini-Mental State Examination (MMSE), which was routinely administered during clinical visits at two centers from 15\u00a0March\u00a0to 31\u00a0October 2017. Patients in the sacubitril/valsartan group had a\u00a0clinical history of at least 3\u00a0months of continuous sacubitril/valsartan administration. The control group comprised CHF patients on conventional therapy not taking sacubitril/valsartan. In the between-group comparison, patients were matched for mean age, educational level, sex, NYHA class, and comorbidities. In the present retrospective study only patients in NYHA class II-III were enrolled.ResultsThe mean MMSE score was 22.72\u202f\u00b1\u20092.68 (mean\u202f\u00b1\u2009standard deviation [SD]) in the sacubitril/valsartan group (n\u202f=\u200951\u00a0patients) vs. 21.96\u202f\u00b1\u20092.73 (mean\u202f\u00b1\u2009SD) in the control group (n\u202f=\u200951; p\u202f=\u20090.1572, independent samples t-test). Thus, a\u00a0similar mild-to-moderate impairment in cognitive performance was found in the comparison between the two groups.ConclusionIn our study, we did not find any evidence of the alleged harmful influence of sacubitril/valsartan on cognitive function. Patients taking sacubitril/valsartan for at least 3\u00a0months had similar mean MMSE scores to control subjects.", 
        "genre": "article", 
        "id": "sg:pub.10.1007/s00059-018-4683-5", 
        "inLanguage": "en", 
        "isAccessibleForFree": false, 
        "isPartOf": [
          {
            "id": "sg:journal.1087175", 
            "issn": [
              "0340-9937", 
              "1615-6692"
            ], 
            "name": "Herz", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "6", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "44"
          }
        ], 
        "keywords": [
          "sacubitril/valsartan", 
          "chronic heart failure", 
          "sacubitril/valsartan group", 
          "Mini-Mental State Examination", 
          "mean MMSE score", 
          "valsartan group", 
          "CHF patients", 
          "heart failure", 
          "clinical data", 
          "control group", 
          "MMSE scores", 
          "cognitive function", 
          "NYHA class II", 
          "retrospective cohort study", 
          "present retrospective study", 
          "beneficial cardiovascular effects", 
          "endogenous natriuretic peptides", 
          "between-group comparison", 
          "central nervous system", 
          "patients' clinical data", 
          "cognitive performance", 
          "neprilysin inhibition", 
          "valsartan administration", 
          "NYHA class", 
          "cardiovascular effects", 
          "cohort study", 
          "neprilysin inhibitor", 
          "retrospective study", 
          "clinical visits", 
          "mean age", 
          "natriuretic peptide", 
          "conventional therapy", 
          "clinical history", 
          "neuronal dysfunction", 
          "moderate impairment", 
          "patients", 
          "cognitive impairment", 
          "nervous system", 
          "State Examination", 
          "valsartan", 
          "class II", 
          "similar mild", 
          "educational level", 
          "impairment", 
          "months", 
          "group", 
          "scores", 
          "failure", 
          "comorbidities", 
          "dysfunction", 
          "ConclusionIn", 
          "therapy", 
          "methodsA", 
          "mild", 
          "sacubitril", 
          "administration", 
          "study", 
          "visits", 
          "age", 
          "sex", 
          "levels", 
          "inhibition", 
          "examination", 
          "subjects", 
          "inhibitors", 
          "effect", 
          "harmful influence", 
          "peptides", 
          "evidence", 
          "function", 
          "history", 
          "center", 
          "comparison", 
          "data", 
          "information", 
          "influence", 
          "degradation", 
          "system", 
          "class", 
          "performance", 
          "BackgroundSacubitril", 
          "combination molecule sacubitril/valsartan", 
          "molecule sacubitril/valsartan", 
          "possible neprilysin inhibition", 
          "continuous sacubitril/valsartan administration", 
          "sacubitril/valsartan administration", 
          "ResultsThe mean MMSE score", 
          "similar mean MMSE scores"
        ], 
        "name": "Cognitive performance of patients with chronic heart failure on sacubitril/valsartan", 
        "pagination": "534-540", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1101042334"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1007/s00059-018-4683-5"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "29450561"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1007/s00059-018-4683-5", 
          "https://app.dimensions.ai/details/publication/pub.1101042334"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-01-01T18:48", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_781.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1007/s00059-018-4683-5"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00059-018-4683-5'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00059-018-4683-5'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00059-018-4683-5'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00059-018-4683-5'


     

    This table displays all metadata directly associated to this object as RDF triples.

    235 TRIPLES      22 PREDICATES      128 URIs      117 LITERALS      18 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1007/s00059-018-4683-5 schema:about N0760abf89e7a46799adb4063776829fe
    2 N435ab7294296499fa0ea507c1b88c930
    3 N6ec3462361d34d8eb8c204ab24d2a50e
    4 N71cb6fa6cd8a4aceb1d76b07be34033e
    5 N7cf5ba0ccd6d47769b0fee9a1d6ce496
    6 N7d14b6fd013649e9bd5b2d7a6cfebc34
    7 Na38122a99fd24c33977b4f7de9087532
    8 Nabe94264a0df4101bcedfdc88861b483
    9 Nce60ec09065e417d831ea38faf233d59
    10 Ne104235277f94d48b131feaf6511cd78
    11 Ne69d0d02a4974a1791e6803efb7e78b0
    12 anzsrc-for:11
    13 anzsrc-for:1102
    14 schema:author N09e6b2aa8a5449e491eb701e87d3675f
    15 schema:citation sg:pub.10.1007/s00059-017-4626-6
    16 sg:pub.10.1007/s12576-017-0525-0
    17 sg:pub.10.1038/nrcardio.2016.200
    18 schema:datePublished 2018-02-15
    19 schema:datePublishedReg 2018-02-15
    20 schema:description BackgroundSacubitril, a neprilysin inhibitor in the combination molecule sacubitril/valsartan, slows down degradation of endogenous natriuretic peptides, thereby enhancing their beneficial cardiovascular effects. However, sacubitril might also promote neuronal dysfunction and cognitive impairment in patients with chronic heart failure (CHF) treated with sacubitril/valsartan, due to possible neprilysin inhibition at the level of Central Nervous System.MethodsA retrospective cohort study was undertaken to detect the effects exerted by sacubitril/valsartan on cognitive function in CHF patients. The patients’ clinical data were examined for information provided in the Mini-Mental State Examination (MMSE), which was routinely administered during clinical visits at two centers from 15 March to 31 October 2017. Patients in the sacubitril/valsartan group had a clinical history of at least 3 months of continuous sacubitril/valsartan administration. The control group comprised CHF patients on conventional therapy not taking sacubitril/valsartan. In the between-group comparison, patients were matched for mean age, educational level, sex, NYHA class, and comorbidities. In the present retrospective study only patients in NYHA class II-III were enrolled.ResultsThe mean MMSE score was 22.72 ± 2.68 (mean ± standard deviation [SD]) in the sacubitril/valsartan group (n = 51 patients) vs. 21.96 ± 2.73 (mean ± SD) in the control group (n = 51; p = 0.1572, independent samples t-test). Thus, a similar mild-to-moderate impairment in cognitive performance was found in the comparison between the two groups.ConclusionIn our study, we did not find any evidence of the alleged harmful influence of sacubitril/valsartan on cognitive function. Patients taking sacubitril/valsartan for at least 3 months had similar mean MMSE scores to control subjects.
    21 schema:genre article
    22 schema:inLanguage en
    23 schema:isAccessibleForFree false
    24 schema:isPartOf N4cc25269c8e84359aa10e9b3fa0df182
    25 N7e847ed70ea34ccd9fe8832566d29f6d
    26 sg:journal.1087175
    27 schema:keywords BackgroundSacubitril
    28 CHF patients
    29 ConclusionIn
    30 MMSE scores
    31 Mini-Mental State Examination
    32 NYHA class
    33 NYHA class II
    34 ResultsThe mean MMSE score
    35 State Examination
    36 administration
    37 age
    38 beneficial cardiovascular effects
    39 between-group comparison
    40 cardiovascular effects
    41 center
    42 central nervous system
    43 chronic heart failure
    44 class
    45 class II
    46 clinical data
    47 clinical history
    48 clinical visits
    49 cognitive function
    50 cognitive impairment
    51 cognitive performance
    52 cohort study
    53 combination molecule sacubitril/valsartan
    54 comorbidities
    55 comparison
    56 continuous sacubitril/valsartan administration
    57 control group
    58 conventional therapy
    59 data
    60 degradation
    61 dysfunction
    62 educational level
    63 effect
    64 endogenous natriuretic peptides
    65 evidence
    66 examination
    67 failure
    68 function
    69 group
    70 harmful influence
    71 heart failure
    72 history
    73 impairment
    74 influence
    75 information
    76 inhibition
    77 inhibitors
    78 levels
    79 mean MMSE score
    80 mean age
    81 methodsA
    82 mild
    83 moderate impairment
    84 molecule sacubitril/valsartan
    85 months
    86 natriuretic peptide
    87 neprilysin inhibition
    88 neprilysin inhibitor
    89 nervous system
    90 neuronal dysfunction
    91 patients
    92 patients' clinical data
    93 peptides
    94 performance
    95 possible neprilysin inhibition
    96 present retrospective study
    97 retrospective cohort study
    98 retrospective study
    99 sacubitril
    100 sacubitril/valsartan
    101 sacubitril/valsartan administration
    102 sacubitril/valsartan group
    103 scores
    104 sex
    105 similar mean MMSE scores
    106 similar mild
    107 study
    108 subjects
    109 system
    110 therapy
    111 valsartan
    112 valsartan administration
    113 valsartan group
    114 visits
    115 schema:name Cognitive performance of patients with chronic heart failure on sacubitril/valsartan
    116 schema:pagination 534-540
    117 schema:productId N310a317fd00f4a17b2cd86d7f6b9e6f4
    118 N64b6d4a573844a9a8b61ae6f42763ae4
    119 Nf388b2f995f34dbb84b4573a6c2b50c5
    120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1101042334
    121 https://doi.org/10.1007/s00059-018-4683-5
    122 schema:sdDatePublished 2022-01-01T18:48
    123 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    124 schema:sdPublisher N2a097a012f51473595132f21678d5dac
    125 schema:url https://doi.org/10.1007/s00059-018-4683-5
    126 sgo:license sg:explorer/license/
    127 sgo:sdDataset articles
    128 rdf:type schema:ScholarlyArticle
    129 N0760abf89e7a46799adb4063776829fe schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    130 schema:name Angiotensin Receptor Antagonists
    131 rdf:type schema:DefinedTerm
    132 N09e6b2aa8a5449e491eb701e87d3675f rdf:first sg:person.0704361014.79
    133 rdf:rest N0eeb84810a7143428685e787e77ec465
    134 N0eeb84810a7143428685e787e77ec465 rdf:first sg:person.0660263343.51
    135 rdf:rest N54688ac687564af8ad993f298ca4a7dc
    136 N2a097a012f51473595132f21678d5dac schema:name Springer Nature - SN SciGraph project
    137 rdf:type schema:Organization
    138 N310a317fd00f4a17b2cd86d7f6b9e6f4 schema:name pubmed_id
    139 schema:value 29450561
    140 rdf:type schema:PropertyValue
    141 N435ab7294296499fa0ea507c1b88c930 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Angiotensin II Type 1 Receptor Blockers
    143 rdf:type schema:DefinedTerm
    144 N4cc25269c8e84359aa10e9b3fa0df182 schema:issueNumber 6
    145 rdf:type schema:PublicationIssue
    146 N54688ac687564af8ad993f298ca4a7dc rdf:first sg:person.01066703417.19
    147 rdf:rest Nc4fec357167347d8880c8177dc8109c4
    148 N64b6d4a573844a9a8b61ae6f42763ae4 schema:name doi
    149 schema:value 10.1007/s00059-018-4683-5
    150 rdf:type schema:PropertyValue
    151 N6ec3462361d34d8eb8c204ab24d2a50e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    152 schema:name Humans
    153 rdf:type schema:DefinedTerm
    154 N71cb6fa6cd8a4aceb1d76b07be34033e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    155 schema:name Retrospective Studies
    156 rdf:type schema:DefinedTerm
    157 N7cf5ba0ccd6d47769b0fee9a1d6ce496 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    158 schema:name Heart Failure
    159 rdf:type schema:DefinedTerm
    160 N7d14b6fd013649e9bd5b2d7a6cfebc34 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    161 schema:name Tetrazoles
    162 rdf:type schema:DefinedTerm
    163 N7e847ed70ea34ccd9fe8832566d29f6d schema:volumeNumber 44
    164 rdf:type schema:PublicationVolume
    165 Na38122a99fd24c33977b4f7de9087532 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    166 schema:name Valsartan
    167 rdf:type schema:DefinedTerm
    168 Nabe94264a0df4101bcedfdc88861b483 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    169 schema:name Drug Combinations
    170 rdf:type schema:DefinedTerm
    171 Nc4fec357167347d8880c8177dc8109c4 rdf:first sg:person.01077606445.25
    172 rdf:rest rdf:nil
    173 Nce60ec09065e417d831ea38faf233d59 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    174 schema:name Cognition
    175 rdf:type schema:DefinedTerm
    176 Ne104235277f94d48b131feaf6511cd78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    177 schema:name Aminobutyrates
    178 rdf:type schema:DefinedTerm
    179 Ne69d0d02a4974a1791e6803efb7e78b0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    180 schema:name Stroke Volume
    181 rdf:type schema:DefinedTerm
    182 Nf388b2f995f34dbb84b4573a6c2b50c5 schema:name dimensions_id
    183 schema:value pub.1101042334
    184 rdf:type schema:PropertyValue
    185 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    186 schema:name Medical and Health Sciences
    187 rdf:type schema:DefinedTerm
    188 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
    189 schema:name Cardiorespiratory Medicine and Haematology
    190 rdf:type schema:DefinedTerm
    191 sg:journal.1087175 schema:issn 0340-9937
    192 1615-6692
    193 schema:name Herz
    194 schema:publisher Springer Nature
    195 rdf:type schema:Periodical
    196 sg:person.01066703417.19 schema:affiliation grid-institutes:None
    197 schema:familyName Di Biase
    198 schema:givenName G.
    199 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01066703417.19
    200 rdf:type schema:Person
    201 sg:person.01077606445.25 schema:affiliation grid-institutes:grid.461820.9
    202 schema:familyName Noutsias
    203 schema:givenName M.
    204 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01077606445.25
    205 rdf:type schema:Person
    206 sg:person.0660263343.51 schema:affiliation grid-institutes:grid.413503.0
    207 schema:familyName Ariano
    208 schema:givenName C.
    209 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0660263343.51
    210 rdf:type schema:Person
    211 sg:person.0704361014.79 schema:affiliation grid-institutes:None
    212 schema:familyName De Vecchis
    213 schema:givenName R.
    214 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0704361014.79
    215 rdf:type schema:Person
    216 sg:pub.10.1007/s00059-017-4626-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1091896405
    217 https://doi.org/10.1007/s00059-017-4626-6
    218 rdf:type schema:CreativeWork
    219 sg:pub.10.1007/s12576-017-0525-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083524408
    220 https://doi.org/10.1007/s12576-017-0525-0
    221 rdf:type schema:CreativeWork
    222 sg:pub.10.1038/nrcardio.2016.200 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003829077
    223 https://doi.org/10.1038/nrcardio.2016.200
    224 rdf:type schema:CreativeWork
    225 grid-institutes:None schema:alternateName Division of Geriatrics, Clinic “S. Maria del Pozzo”, via Pomigliano 40, 80049, Somma Vesuviana, Italy
    226 Preventive Cardiology and Rehabilitation Unit, DSB 29 “S. Gennaro dei Poveri Hospital”, via S. Gennaro dei Poveri 25, 80136, Naples, Italy
    227 schema:name Division of Geriatrics, Clinic “S. Maria del Pozzo”, via Pomigliano 40, 80049, Somma Vesuviana, Italy
    228 Preventive Cardiology and Rehabilitation Unit, DSB 29 “S. Gennaro dei Poveri Hospital”, via S. Gennaro dei Poveri 25, 80136, Naples, Italy
    229 rdf:type schema:Organization
    230 grid-institutes:grid.413503.0 schema:alternateName Division of Geriatrics, “Casa Sollievo della Sofferenza” Hospital, viale Cappuccini 2, 71013, San Giovanni Rotondo, Italy
    231 schema:name Division of Geriatrics, “Casa Sollievo della Sofferenza” Hospital, viale Cappuccini 2, 71013, San Giovanni Rotondo, Italy
    232 rdf:type schema:Organization
    233 grid-institutes:grid.461820.9 schema:alternateName Mid-German Heart Center, Department of Internal Medicine III, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Halle, Martin Luther University Halle-Wittenberg, Ernst-Grube-Straße 40, 06120, Halle, Germany
    234 schema:name Mid-German Heart Center, Department of Internal Medicine III, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Halle, Martin Luther University Halle-Wittenberg, Ernst-Grube-Straße 40, 06120, Halle, Germany
    235 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...